ACAD Acadia Pharmaceuticals PE ratio, current and historical analysis
The P/E ratio for Acadia Pharmaceuticals stock stands at 12.82 as of Mar 7, 2025. The calculation is based on the latest EPS of $1.37 and the stock price of $17.56 per share.
ACAD PE ratio history
Acadia Pharmaceuticals PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 13.39 | N/A | $18.35 | $1.37 |
| 2023 | N/A | N/A | $31.31 | -$0.37 |
| 2022 | N/A | N/A | $15.92 | -$1.34 |
| 2021 | N/A | N/A | $23.34 | -$1.05 |
| 2020 | N/A | N/A | $53.46 | -$1.79 |
| 2019 | N/A | N/A | $42.78 | -$1.6 |
| 2018 | N/A | N/A | $16.17 | -$1.94 |
| 2017 | N/A | N/A | $30.11 | -$2.36 |
| 2016 | N/A | N/A | $28.84 | -$2.34 |
| 2015 | N/A | N/A | $35.65 | -$1.63 |
| 2014 | N/A | N/A | $31.75 | -$0.95 |
| 2013 | N/A | N/A | $24.99 | -$0.44 |
| 2012 | N/A | N/A | $4.65 | -$0.38 |
| 2011 | N/A | N/A | $1.08 | -$0.44 |
| 2010 | 3.08 | N/A | $1.2 | $0.39 |
Acadia Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 13.39 | -32.1% | $18.35 | $1.37 |
| Sep 2024 | 19.72 | -78.16% | $15.38 | $0.78 |
| Jun 2024 | 90.28 | N/A | $16.25 | $0.18 |
| Mar 2024 | N/A | N/A | $18.49 | -$0.01 |
| Dec 2023 | N/A | N/A | $31.31 | -$0.37 |
| Sep 2023 | N/A | N/A | $20.84 | -$0.92 |
| Jun 2023 | N/A | N/A | $23.95 | -$0.69 |
| Mar 2023 | N/A | N/A | $18.82 | -$0.91 |
| Dec 2022 | N/A | N/A | $15.92 | -$1.34 |
| Sep 2022 | N/A | N/A | $16.36 | -$1.35 |
| Jun 2022 | N/A | N/A | $14.09 | -$1.27 |
| Mar 2022 | N/A | N/A | $24.22 | -$1.33 |
| Dec 2021 | N/A | N/A | $23.34 | -$1.05 |
| Sep 2021 | N/A | N/A | $16.61 | -$1.2 |
| Jun 2021 | N/A | N/A | $24.39 | -$1.65 |
ACAD average PE ratio chart
ACAD PE vs peers
When compared to its peer stocks LLY and JNJ, ACAD's PE ratio is lower.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ACAD Acadia Pharmaceuticals Inc | 12.82 | $2.93B |
| PFE Pfizer Inc | 18.82 | $151.49B |
| JNJ Johnson & Johnson | 28.54 | $401.33B |
| LLY ELI LILLY & Co | 73.94 | $824.51B |
| VNDA Vanda Pharmaceuticals Inc | N/A | $282.83M |
| BMY Bristol Myers Squibb Co | N/A | $123.97B |
Frequently asked questions
What is Acadia Pharmaceuticals's PE ratio?
The price to earnings ratio for ACAD stock as of Mar 7, 2025, stands at 12.82.
How is ACAD's PE ratio calculated (Acadia Pharmaceuticals PE ratio formula)?
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Mar 7, 2025), Acadia Pharmaceuticals's share price is $17.56. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $1.37. Therefore, Acadia Pharmaceuticals's price to earnings ratio for today is 12.82. PE RATIO(12.82) = STOCK PRICE($17.56) / TTM EPS($1.37)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.